NANO-X IMAGING LTD Files 2020 Annual Report on Form 20-F

Rhea-AI Summary

Nano-X Imaging Ltd (NASDAQ: NNOX) has filed its annual report on Form 20-F for the fiscal year ending December 31, 2020, with the SEC on April 6, 2021. The report includes audited consolidated financial statements, accessible on the SEC's website and Nano-X’s official site. The company emphasizes its mission to democratize healthcare through innovative medical imaging technology, which aims to make imaging services more affordable. Shareholders can request a hard copy of the report free of charge by contacting Investor Relations.

Positive

• Filed annual report on Form 20-F for fiscal year 2020.
• Focus on democratizing healthcare through innovative imaging technology.
• Accessibility of financial statements on SEC and company websites.

Negative

• None.

NEVE ILAN, Israel, April 06, 2021 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (www.nanox.vision) (“Nanox” or the “Company”), the innovative medical imaging technology company democratizing healthcare, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2020 with the U.S. Securities and Exchange Commission (“SEC”) on April 6, 2021. The annual report on Form 20-F, which contains the Company’s audited consolidated financial statements, can be accessed on the SEC’s website at www.sec.gov and on the Company’s website at www.nanox.vision under “Financials” in the Investors section.

The Company will provide a hard copy of its annual report containing its audited consolidated financial statements, free of charge, to its shareholders upon request. Requests should be directed to Investor Relations, at IR@nanox.vision.

About NANO-X:

Nano-X, founded by the serial entrepreneur Ran Poliakine is an Israeli corporation developing a commercial-grade digital X-ray source designed to be used in real-world medical imaging applications. Nano-X believes that its novel technology could significantly reduce the costs of medical imaging systems and plans to seek collaborations with world-leading healthcare organizations and companies to provide affordable, early detection imaging service for all. For more information, please visit www.nanox.vision.

Contact:

Itzhak Maayan
Nanox Imaging
IR@nanox.vision

Bob Yedid
LifeSci Advisors
bob@lifesciadvisors.com

FAQ

What is the significance of the annual report filed by NANO-X Imaging Ltd on April 6, 2021?

The annual report on Form 20-F contains audited consolidated financial statements that provide insights into the company's financial health for the fiscal year ended December 31, 2020.

Where can I access the annual report of NANO-X Imaging Ltd?

The annual report can be accessed on the SEC's website and on Nano-X's official website under the 'Financials' section.

What are Nano-X Imaging’s goals regarding medical imaging?

Nano-X Imaging aims to democratize healthcare by reducing the costs of medical imaging systems and collaborating with leading healthcare organizations.

How can shareholders obtain a hard copy of Nano-X Imaging's annual report?

Shareholders can request a hard copy of the annual report free of charge by contacting Investor Relations at IR@nanox.vision.